{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:55:31Z","timestamp":1793854531816,"version":"4.6.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Historically, antimicrobial resistance has been rare in US invasive meningococcal disease cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Meningococcal isolates (n\u2005=\u2005695) were collected through population-based surveillance, 2012\u20132016, and national surveillance, 2015\u20132016. Antimicrobial susceptibility was assessed by broth microdilution. Resistance mechanisms were characterized using whole-genome sequencing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>All isolates were susceptible to 6 antibiotics (cefotaxime, ceftriaxone, meropenem, rifampin, minocycline, and azithromycin). Approximately 25% were penicillin or ampicillin intermediate; among these, 79% contained mosaic penA gene mutations. Less than 1% of isolates were penicillin, ampicillin, ciprofloxacin, or levofloxacin resistant.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Penicillin- and ampicillin-intermediate isolates were common, but resistance to clinically relevant antibiotics remained rare.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiac046","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T20:11:22Z","timestamp":1644351082000},"page":"1871-1875","source":"Crossref","is-referenced-by-count":30,"title":["Antimicrobial Susceptibility Survey of Invasive <i>Neisseria meningitidis<\/i>, United States 2012\u20132016"],"prefix":"10.1093","volume":"225","author":[{"given":"Caelin C","family":"Potts","sequence":"first","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine D","family":"Rodriguez-Rivera","sequence":"additional","affiliation":[{"name":"Weems Design Studio, Inc, Contractor assigned to Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"},{"name":"IHRC, Inc, Contractor assigned to Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C","family":"Retchless","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Hu","sequence":"additional","affiliation":[{"name":"IHRC, Inc, Contractor assigned to Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henju","family":"Marjuki","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E","family":"Blain","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A","family":"McNamara","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"2022060115040786400_CIT0001","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jinf.2018.06.008","article-title":"Population structure of invasive Neisseria meningitidis in the United States, 2011\u201315.","volume":"77","author":"Potts","year":"2018","journal-title":"J Infect"},{"key":"2022060115040786400_CIT0002","volume-title":"Red Book: 2021 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics Committee on Infectious Disease","year":"2021","edition":"32"},{"key":"2022060115040786400_CIT0003","doi-asserted-by":"crossref","first-page":"735","DOI":"10.15585\/mmwr.mm6924a2","article-title":"Detection of ciprofloxacin-resistant, \u03b2-lactamase-producing Neisseria meningitidis serogroup Y isolates\u2014United States, 2019\u20132020.","volume":"69","author":"McNamara","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022060115040786400_CIT0004","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine.","volume":"66","author":"McNamara","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022060115040786400_CIT0005","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/cid\/ciab358","article-title":"Acquisition of ciprofloxacin resistance among an expanding clade of \u03b2-lactamase-positive, serogroup Y Neisseria meningitidis in the United States.","volume":"73","author":"Potts","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022060115040786400_CIT0006","doi-asserted-by":"crossref","first-page":"ofv117","DOI":"10.1093\/ofid\/ofv117","article-title":"Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States.","volume":"2","author":"Harcourt","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"2022060115040786400_CIT0007","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1128\/JCM.01903-06","article-title":"Emergence of non-ceftriaxone-susceptible Neisseria meningitidis in India.","volume":"44","author":"Manchanda","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2022060115040786400_CIT0008","author":"Instituto"},{"key":"2022060115040786400_CIT0009","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1128\/JCM.02495-06","article-title":"Emergence of non-ceftriaxone-susceptible Neisseria meningitidis in India.","volume":"45","author":"Nicolas","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2022060115040786400_CIT0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/dkw400","article-title":"Emergence of meningococci with reduced susceptibility to third-generation cephalosporins.","volume":"72","author":"Deghmane","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2022060115040786400_CIT0011","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/AAC.00412-07","article-title":"Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.","volume":"51","author":"Taha","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2022060115040786400_CIT0012","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1128\/AAC.00315-10","article-title":"Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.","volume":"54","author":"Taha","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2022060115040786400_CIT0013","doi-asserted-by":"crossref","first-page":"e01494","DOI":"10.1128\/AAC.01494-19","article-title":"Meningococcal quinolone resistance originated from several commensal Neisseria species.","volume":"64","author":"Chen","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2022060115040786400_CIT0014","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/AAC.02184-12","article-title":"Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.","volume":"57","author":"Hong","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2022060115040786400_CIT0015","author":"Centers for Disease Control and Prevention, National Notifiable Diseases Surveillance System."},{"key":"2022060115040786400_CIT0016","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI).","year":"2020","edition":"30"},{"key":"2022060115040786400_CIT0017","doi-asserted-by":"crossref","first-page":"e00207","DOI":"10.1128\/AAC.00207-18","article-title":"Neisseria meningitidis antimicrobial resistance in Italy, 2006 to 2016.","volume":"62","author":"Vacca","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022060115040786400_CIT0018","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/AAC.01077-09","article-title":"Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.","volume":"54","author":"Brown","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2022060115040786400_CIT0019","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1473-3099(14)70806-0","article-title":"Epidemiology of invasive meningococcal disease in the Netherlands, 1960\u20132012: an analysis of national surveillance data.","volume":"14","author":"Bijlsma","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2022060115040786400_CIT0020","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1128\/AAC.06310-11","article-title":"Evolutionary changes in antimicrobial resistance of invasive Neisseria meningitidis isolates in Belgium from 2000 to 2010: increasing prevalence of penicillin nonsusceptibility.","volume":"56","author":"Bertrand","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2022060115040786400_CIT0021","doi-asserted-by":"crossref","first-page":"ofw152","DOI":"10.1093\/ofid\/ofw152","article-title":"Penicillin use in meningococcal disease management: active bacterial core surveillance sites, 2009.","volume":"3","author":"Blain","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2022060115040786400_CIT0022","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1128\/AAC.00378-16","article-title":"Use of animal models to support revising meningococcal breakpoints of beta-lactams.","volume":"60","author":"Belkacem","year":"2016","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiac046\/43335458\/jiac046.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/11\/1871\/43918277\/jiac046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/11\/1871\/43918277\/jiac046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T15:04:44Z","timestamp":1654095884000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/225\/11\/1871\/6546244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,3,10]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiac046","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,3,10]]}}}